Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection

PURPOSE. Genotype-guided antiplatelet therapy is increasingly being incorporated into clinical care. The purpose of this study is to determine the extent to which patients initially genotyped for CYP2C19 to guide antiplatelet therapy were prescribed additional medications affected by CYP2C19. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Beitelshees, Amber L., Stevenson, James M., El Rouby, Nihal, Dillon, Chrisly, Empey, Philip E., Fielstein, Elliot M., Johnson, Julie A., Limdi, Nita A., Ong, Henry H., Franchi, Francesco, Angiolillo, Dominick P., Peterson, Joshua F., Rosenman, Marc B., Skaar, Todd C., Tuteja, Sony, Cavallari, Larisa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606808/
https://www.ncbi.nlm.nih.gov/pubmed/32678355
http://dx.doi.org/10.1038/s41436-020-0894-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606808/
https://www.ncbi.nlm.nih.gov/pubmed/32678355
http://dx.doi.org/10.1038/s41436-020-0894-2

Ejemplares similares